In both breast cancer [5] and lung cancer [6] drug-resistant cells, the level of FEN1 medicated DNA damage repair was significantly increased and the inhibition of FEN1 expression could promoted the drug-resistant cells sensitivity to Tamoxifen and Cisplatin respectively. The gene discussed is FEN1; the disease is breast carcinoma.